MetaPharm Inc. International has a proven track record in managing all major indications in clinical phases II – IV, including paediatric trials, orphan drugs and medical devices, non-interventional studies (NIS) and post-authorization studies. With our close relationships with leading investigators and Key Opinion Leaders worldwide, we deliver the highest quality solutions.